CIK 0002023658
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Meisner Lara Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2025-09-29 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +33,807 | $9.24 | $312K | 33,807 |
| 2025-09-29 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −33,807 | $14.75 | $499K | 0 |
| 2025-09-29 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −33,807 | 101,423 | ||
| 2025-09-15 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +15,829 | $5.45 | $86K | 15,829 |
| 2025-09-15 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −15,829 | $11.49 | $182K | 0 |
| 2025-09-15 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,085 | 54,769 | ||
| 2025-09-15 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,744 | 87,699 | ||
| 2025-06-16 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +15,829 | $5.45 | $86K | 15,829 |
| 2025-06-16 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −15,829 | $10.43 | $165K | 0 |
| 2025-06-16 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,085 | 60,854 | ||
| 2025-06-16 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,744 | 97,443 | ||
| 2025-03-14 | Meisner Lara Chief Legal Officer | Option exercise 10b5-1 | +79,146 | $5.45 | $431K | 79,145 |
| 2025-03-14 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −48,526 | $12.69 | $616K | 30,620 |
| 2025-03-14 | Meisner Lara Chief Legal Officer | Sale 10b5-1 | −30,620 | $13.24 | $406K | 0 |
| 2025-03-14 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −48,720 | 107,187 | ||
| 2025-03-14 | Meisner Lara Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,246 | 67,119 |
Page 1 of 1 · 17 trades